Quetiapine Fumarate contains not less than 98.0 per cent and not more than 102.0 per cent of (C21H25N3O2S)2‧C4H4O4 calculated on the dried basis.

共有 1 個藥物證書使用此成份

延胡索酸奎提亞平
Quetiapine Fumarate

• 申請商: 漢旭股份有限公司
• 適應症: 思覺失調症，雙極性疾患之躁症發作。
• 發證日期: 2017-08-19